AF Ablation: Surgery And Catheter Techniques Both Shine At AHA
This article was originally published in The Gray Sheet
Executive Summary
Atrial fibrillation treatments involving standalone surgical ablation and catheter ablation were discussed in data presentations at the American Heart Association annual meeting last week.
You may also be interested in...
Medtronic Studies Cryoballoon As First-Line Atrial Fibrillation Option
The firm will recruit over 200 patients across 12 European sites to evaluate if its Arctic Front Advance ablation therapy can benefit as a first-line treatment for atrial fibrillation rather than drugs.
News Briefs: Medtronic’s CoreValve Approval; J&J Dx Unit Set For Sale; Google’s Glucometer Contact Lens
Medtronic gains FDA approval for its transcather CoreValve system months earlier than predicted. The Carlyle Group makes binding offer for J&J’s Ortho-Clinical Diagnostics business. Google is developing a wireless glucometer embedded within a contact lens. More news briefs.
FDA Panel Narrowly Endorses AtriCure’s Synergy For A-Fib Ablation
FDA’s Circulatory System Devices panel narrowly endorsed an expanded indication last week for AtriCure’s Synergy ablation system to treat certain types of atrial fibrillation during open-heart surgery, despite concerns over safety issues and limited data.